Chronic Infections and Inflammation in ME/CFS
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at how chronic infections and inflammation affect people with ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) compared to healthy people. Researchers want to understand what causes symptoms and find better ways to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a diagnosis of ME/CFS, or you are a healthy person without any infection-related chronic conditions.
- You do not have severe anemia (hemoglobin below 9 g/dL).
- You do not have HIV, hepatitis B, or hepatitis C.
- You do not have another infection-related chronic condition like chronic Lyme disease or post-Ebola syndrome (unless it is Long COVID).
- You do not have a serious medical or psychiatric illness that would make it hard to follow the study rules.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how post-exertional malaise (PEM) affects people with ME/CFS. It aims to understand the condition better and find new ways to help.
This study tests whether acupuncture can help improve thinking and memory problems in people with long-term fatigue after COVID-19 (often called ME/CFS). If you have had fatigue for at least 6 months after a COVID-19 infection and meet specific criteria, this trial may offer a non-drug treatment option.
This study looks at what daily symptoms and experiences people with chronic fatigue syndrome go through. It may help researchers understand patterns that could improve future care, and it includes people who have not started treatment for this condition yet.
This study is tracking children, teens, and young adults (up to age 25) who developed ME/CFS after an infection. It aims to better understand the condition in younger people.
This study observes how a blood-cleaning treatment called immunoadsorption works in patients with ME/CFS (severe fatigue condition) who have specific immune markers. Researchers will track whether this treatment helps reduce symptoms and improve daily functioning.
This study looks for healthy people ages 10–25 to compare with those who have ME/CFS, to help find better ways to diagnose the condition. Volunteers will help researchers understand what's normal and what's not.
Hear when a new Myalgic Encephalomyelitis/Chronic Fatigue Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.